Back to List

Eli Lilly and Company

lilly.com

Lilly 30x30 is the company's goal to create new access to quality health care for 30 million people in resource-limited settings by the year 2030. To reach that goal, we have to find new solutions across our business and with our partners.

COLLABORATIONS

SHOWING 5 of 20 COLLABORATIONS

See All

Access Accelerated Initiative

Tackling the growing burden of non-communicable diseases in low and middle-income countries and supporting...

Access Accelerated, Almirall, Astellas Pharma Inc, Bayer AG, Bristol Myers Squibb, Celgene, Chiesi Farmaceutici, Chugai Pharmaceutical, Daiichi Sankyo, Eisai, Eli Lilly and Company, F. Hoffmann – La Roche Ltd., International Federation of Pharmaceutical Manufacturers & Associations, Johnson & Johnson, Menarini Group, Merck, MSD, Novartis, Pfizer Inc, Sanofi, Servier, Shionogi & Co., Ltd., Sumitomo Pharma, Takeda Pharmaceutical Company Limited, UCB

SHOWING 5 of 20 COLLABORATIONS

See All